Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ADIL
ADIL
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ADIL News
Adial Pharmaceuticals Reports Q1 2026 Business Update and Financial Results
May 11 2026
Newsfilter
Adial Files Patent Application for AD04 to Enhance Market Competitiveness
Apr 29 2026
Newsfilter
Adial Submits AD04 Application for FDA Fast-Track Review
Apr 27 2026
NASDAQ.COM
Adial Submits AD04 Application for FDA Fast-Track Review
Apr 27 2026
Newsfilter
Adial Pharmaceuticals Completes Successful AD04 Demonstration Batch Production
Apr 22 2026
Newsfilter
Adial Pharmaceuticals Reports Reduced Net Loss for 2025
Mar 06 2026
seekingalpha
Adial Pharmaceuticals Highlights FDA's New Policy Direction on Drug Approval
Feb 23 2026
Newsfilter
Adial Pharmaceuticals to Present at Oppenheimer Conference
Feb 17 2026
Yahoo Finance
U.S. Stocks Decline in Morning Trading
Feb 05 2026
Benzinga
U.S. Stocks Mixed; Eli Lilly Shares Surge After Earnings Beat
Feb 04 2026
Benzinga
U.S. Stocks Mixed in Morning Trading
Feb 04 2026
Benzinga
Adial Pharmaceuticals Applauds New Legislation for Addiction Treatment
Feb 04 2026
Newsfilter
Super Micro Computer Q2 Earnings Exceed Expectations
Feb 04 2026
Benzinga
Adial Pharmaceuticals Announces 1-for-25 Reverse Stock Split
Feb 04 2026
stocktwits
Adial Pharmaceuticals to Execute 1-for-25 Reverse Stock Split
Feb 03 2026
seekingalpha
Adial Pharmaceuticals Enters Warrant Inducement Agreement, Raising $2.86 Million
Nov 26 2025
Globenewswire
Show More News
